S&P 500 6,910.39 ↓ 3.7%Dow Jones 48,147.33 ↓ 1.93%Nasdaq 22,617.73 ↓ 5.28%BTC $60,741 ↑ 3.4%ETH $1,705 ↑ 2.7%EUR/USD 1.099Inflation 3.5% YoYLive market dataS&P 500 6,910.39 ↓ 3.7%Dow Jones 48,147.33 ↓ 1.93%Nasdaq 22,617.73 ↓ 5.28%BTC $60,741 ↑ 3.4%ETH $1,705 ↑ 2.7%EUR/USD 1.099Inflation 3.5% YoYLive market data

The "CRUSH" Rule: Why a Medicare Audit Proposal Knocked Billions Off Health Insurer Stocks, and What It Means for Your Portfolio

A proposed federal rule on Medicare Advantage audits sent UnitedHealth, Humana and other insurers tumbling on the November 18 session. Here is what it actually says, why the reaction was so sharp, and how a long-term investor should think about it.
The "CRUSH" Rule: Why a Medicare Audit Proposal Knocked Billions Off Health Insurer Stocks, and What It Means for Your Portfolio

Key takeaways

  • CMS proposed a broad rule nicknamed CRUSH on November 16, 2026, and health insurer stocks fell sharply, with the steepest drop in the group on the November 18 session.
  • The rule would extrapolate audit error rates across an insurer's entire Medicare Advantage contract beginning with payment year 2018, and would codify not applying a fee-for-service adjuster that CMS says it never actually calculated or implemented.
  • For payment years 2011 through 2017, the proposal does not extrapolate and instead describes collecting only the non-extrapolated overpayments identified in prior audits.
  • Keep two figures apart: CMS estimates an average of about $9 billion per audited payment year in Medicare Advantage overpayment recoveries, while HHS projects close to $90 billion in savings from the entire rule across Medicare, Medicaid, CHIP and the Marketplace from 2027 to 2036.
  • Humana is among the most exposed because roughly $99.4 billion of its about $129.7 billion in 2025 revenue came from Medicare Advantage.
  • The rule is only a proposal, with comments open until January 19, 2027, and analysts expect a legal challenge like the one that struck down a similar earlier framework on procedural grounds.
Send this guide

It goes to your followers on the network you pick.

If you own a broad stock index fund, a slice of your money sits in the big health insurers, and this week those stocks took a beating. The trigger was not an earnings miss or a scandal. It was a proposed federal rule with a blunt nickname: CRUSH. In the sessions after the proposal came out, shares of UnitedHealth, Humana and CVS Health fell hard, and on the November 18 session the health care selling, along with hawkish Federal Reserve minutes, helped drag the Dow down 561.25 points to 50,198.17 even as the broader market held up better, according to market-close reporting for that day. One widely shared recap of that close came from an overseas outlet in its own morning hours, a reminder to match the numbers to the trading date, not the time stamp. Here is what the rule actually says, why Wall Street reacted the way it did, and what it means if you are a long-term saver rather than a day trader.

What the CRUSH rule is

On November 16, 2026, the Department of Health and Human Services and the Centers for Medicare and Medicaid Services, the agency most people just call CMS, released a proposed rule they named Comprehensive Regulations to Uncover Suspicious Healthcare, or CRUSH. It is a broad rule that touches Medicare, Medicaid, the Children's Health Insurance Program and the Health Insurance Marketplace. The piece that rattled investors is aimed at Medicare Advantage, the privately run version of Medicare that now covers a large share of older Americans. The government pays insurers more to cover sicker patients, so there is a built-in financial reason for plans to document every diagnosis they can. CMS argues that some of that documentation leads to overpayments, and CRUSH is designed to recover that money.

It helps to keep two numbers apart. CMS estimates the Medicare Advantage audit approach alone could recover an average of about $9 billion per audited payment year in overpayments. That figure describes the audited payments, not a yearly collection schedule, and any money would arrive later and over time. Separately, HHS projects that the entire CRUSH rule, across all of those programs and not just the Medicare Advantage audits, could produce close to $90 billion in federal savings between 2027 and 2036, per the proposal as summarized in trade coverage. The bigger figure is a whole-rule estimate, not the price tag of the audit change by itself. Public comments are open until January 19, 2027, so none of this is final.

Two words that spooked investors: extrapolate and adjuster

The frightening part for insurers is not that the government audits them. It is how CRUSH would do the arithmetic. Today, when CMS runs a risk adjustment data validation audit, it reviews a sample of patient records. The proposal would take the error rate found in that sample and apply it across an insurer's entire Medicare Advantage contract, a technique called extrapolation. A small sample of mistakes could translate into a very large bill.

The second change is quieter, and it is easy to get backward. Years ago, in its 2012 audit methodology, CMS said it intended to apply a fee-for-service adjuster, a factor meant to account for the fact that coding gaps also show up in traditional Medicare. In this proposal CMS says it never actually calculated or implemented that adjuster in any audit. So CRUSH does not take away a discount insurers had been enjoying. Instead, it would write the nonapplication of that long-contemplated adjuster into the regulation, locking in current practice. Pair that with extrapolation of audit findings beginning with payment year 2018, and the potential look-back liability grows in a way companies cannot yet size with any confidence. For the earlier payment years 2011 through 2017, the proposal does not extrapolate at all and instead describes collecting only the non-extrapolated overpayments identified in past audits.

How the stocks moved

The market did what markets do when faced with a big unknown: it sold first and asked questions later. The steepest drop in the managed care names came on the November 18 session.

One honest caveat on those numbers: different outlets reported somewhat different percentage moves for the same day depending on exactly when they captured the price, so treat these as point-in-time session quotes rather than precise official closes. Either way, these are not small companies. UnitedHealth and the other managed-care names are heavyweight members of major indexes, which is why a rule aimed at one corner of the health system rippled into the Dow and into funds owned by people who have never once thought about Medicare billing.

Why Humana had the most to lose

Not every insurer is equally exposed. The more of a company's business that runs through Medicare Advantage, the more a clawback rule stings. Humana is the clearest example. Of its roughly $129.7 billion in 2025 revenue, about $99.4 billion came from Medicare Advantage, according to figures cited in reporting on the selloff. When nearly four of every five dollars depend on one program, a rule that reshapes that program's payments hits the whole business.

Nobody knows the final bill yet

Here is the honest part: the actual cost to any single insurer is genuinely uncertain. Analysts who cover the group have cautioned that the potential repayments are hard to size and that the industry will push back hard, both in the public comment process and, very likely, in court. The clearest official number remains CMS's own estimate of an average of about $9 billion per audited payment year in Medicare Advantage recoveries, and even that depends on a method that has not yet survived a legal test.

That uncertainty is exactly why the stocks fell so much. Markets can price good news and bad news. What they hate is a liability with no clear ceiling and no firm timeline, which is what extrapolation reaching back to payment year 2018, with no fee-for-service adjuster in the math, looks like on paper.

It is still only a proposal

It is worth repeating that CRUSH is a proposed rule, not law. The comment window runs until January 19, 2027, and CMS has been here before. The agency says it is reissuing the extrapolation provisions after a similar earlier framework was struck down in federal court on procedural grounds, so a legal challenge is a real possibility again. Research analysts at Oppenheimer made the same point, arguing the audit rule could meet the same fate as the earlier version that was thrown out in court. Separately, renewed political talk, including Senator Elizabeth Warren's call to break up the largest insurers, added to the pressure. None of those side stories changes the central question, which is how much money the audit math would actually pull back and when.

What it means for your money

If you hold individual insurer shares, this is a moment to read, not to flinch. The size of the hit depends on a rule that is not final, an extrapolation method that still faces a likely court fight, and a comment period that runs into 2027. A headline-driven drop and the real long-term value of a business are not the same thing, which is the whole point of our guide on what a stock is actually worth. If you simply own a total-market or S&P 500 index fund, your exposure to any single insurer is a few percentage points at most, and the fund already spreads your risk across hundreds of other companies.

None of this is a reason to chase or dump a stock on a single week of headlines. If anything, it is a reminder of why steady, diversified saving tends to win out over time. The slider below is a simple hypothetical, not tied to any insurer or to the CRUSH outcome, to show how regular contributions and compounding can build a balance over the years.

The practical takeaway is modest and a little boring, which is usually a good sign in investing. Watch what CMS does with the comments by January, watch whether the rule survives a likely court fight, and watch how each insurer sizes its own potential liability once it has had time to run the numbers. Those are the facts that will settle where these stocks belong. The plunge told you how nervous the market is. It did not tell you how the story ends.

Before you invest another dollar

Most investors cannot pass a basic money test. Can you?

The market charges tuition for every gap in your knowledge. The Financial IQ Test measures what you actually know across investing, banking, credit, and retirement, then shows you exactly which gaps to close before they get expensive.

Test your Financial IQ
The Financial IQ Test is built by our parent company, Advanced Learning Academy. Same family, same standards.

Questions people ask

What does CRUSH stand for?

It is the nickname for a CMS and HHS proposed rule called Comprehensive Regulations to Uncover Suspicious Healthcare. It is a broad rule covering Medicare, Medicaid, CHIP and the Health Insurance Marketplace, but the part that spooked investors targets overpayments in Medicare Advantage, the privately run version of Medicare.

Why did the insurer stocks fall so much on a proposal?

Two features worried investors. CRUSH would extrapolate errors found in a sample of records across a whole contract, beginning with payment year 2018, and it would codify not applying a fee-for-service adjuster. CMS says it never actually calculated or implemented that adjuster, so this writes current practice into the rule rather than removing a protection insurers had relied on. Even so, extrapolation creates a potential liability companies cannot yet size, and markets dislike open-ended unknowns.

Is the rule final? Could it change?

No, it is a proposed rule. Public comments are open until January 19, 2027, and CMS says it is reissuing provisions after a similar earlier framework was struck down in federal court on procedural grounds, so legal challenges are possible. The final version could look different or be delayed.

Which companies are most affected?

Insurers with heavy Medicare Advantage exposure, including UnitedHealth, Humana and CVS Health, saw the steepest drops. Humana stands out because about $99.4 billion of its roughly $129.7 billion in 2025 revenue came from Medicare Advantage.

How much could it actually cost the insurers?

That is genuinely uncertain. Analysts who follow the group say the potential repayments are hard to size and expect the industry to push back, including in court. The clearest official figure is CMS's estimate of an average of about $9 billion per audited payment year in Medicare Advantage overpayment recoveries, which describes the audited payments rather than a yearly collection schedule, and which is separate from the roughly $90 billion in savings HHS projects for the entire rule across several programs.

I own an index fund. Should I do anything?

For most long-term investors the answer is to stay informed, not to react. A broad index fund holds any single insurer at only a few percent, so the drop has a limited effect on a diversified portfolio. The key facts to watch are the January comment deadline and any court challenge.

Just so you know: DollarFlourish is an educational publisher, not a financial, tax, or investment advisor. Numbers and rates change. Verify anything important with a licensed professional before acting on it. Some links on this site may earn us a commission at no cost to you. See how we review.
Send this guide
DollarFlourish Editorial
Data & Research Desk

The DollarFlourish Money Research Team builds the site's calculators and data rankings and writes its research-driven guides. Every figure we publish is traced to a primary source, the Bureau of Labor Statistics, Census Bureau, IRS, Social Security Administration, and Federal Reserve, and dated so you can check it yourself.

Reviewed for accuracy by Timothy E. Parker · Updated 2026-11-19 · Editorial & corrections policy

The Flourish Letter

One smart money idea each week, charts included. Join free and get the printable 2026 Money Calendar in your welcome email.